Osteopontin as a Prognostic Indicator in Grading of Ovarian Epithelial Tumors
Prakash V Patil, SG Karadesai
Citation Information :
Patil PV, Karadesai S. Osteopontin as a Prognostic Indicator in Grading of Ovarian Epithelial Tumors. J South Asian Feder Obs Gynae 2015; 7 (2):61-63.
Cancer statistics review: 1973-1990. Bethesda. MO: National Cancer Institute 1993.
Cancer of ovary. New Engl J Med 2004; 351(24):2519-2529.
Transformed mammalian cells secrete specific proteins and phosphoproteins. Cell 1979; 16(4):885-893.
Osteopontin in metastatic lesions as a prognostic marker in ovarian cancers. J Biomed Sci 2007;14(3):373-381.
Osteopontin expression in ovarian carcinomas and tumors of low malignant potential. Hum Pathol 1998;29(11):1250-1254.
Ovarian surface epithelialstromal tumors. In: Sternberg's diagnostic surgical pathology stacey Miller, E editor. 5th ed. Lippincott Williams and Wilkins 2010;2:2278-2308.
Histopathological grading of ovarian carcinoma: a review and proposal. Int J Gynecol Pathol 2000; 19(1):7-15.
Global cancer statistics, 2002. CA Cancer J Clin 2005 Mar-Apr;55(2):74-108.
National Cancer Registry Program. Indian Council of Medical Res, Bengaluru; 2006.
Cancer statistics, 2006. CA Cancer J Clin 2006;56(2):106-130.
Schorge JO, Feltmate CM, Berkowitz RR, Cramer DW, MoK SC. Osteopontin as a potential diagnostic biomarker for ovarian cancer. JAMA 2002;287(13):1671-1679.
